{"id":"W1972912578","doi":"10.1016/s1470-2045(13)70184-0","title":"Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":287,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Aflibercept; Docetaxel; Medicine; Prednisone; Prostate cancer; Placebo; Clinical endpoint; Internal medicine; Oncology; Chemotherapy; Surgery; Cancer; Bevacizumab; Urology; Randomized controlled trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003337646,0.0001676648,0.0007250297,0.0000884476,0.00007044489,0.00002054704,0.00005692485,0.00004850238,0.00005683813],"category_scores_gemma":[0.00001563699,0.00008154004,0.00003760255,0.0001615294,0.0002300057,0.00009155652,0.00000952307,0.00007077536,0.000001276309],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003550428,"about_ca_system_score_gemma":0.0006097909,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008561152,"about_ca_topic_score_gemma":0.001487855,"domain_scores_codex":[0.9988593,0.0001405895,0.0002815601,0.0002300603,0.0001835521,0.000304914],"domain_scores_gemma":[0.9989219,0.0004695832,0.0001897521,0.0001891307,0.0001519946,0.00007769747],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9840288,0.001651389,0.0001553194,0.000126217,0.0006323616,0.00002213346,0.003260221,0.00003301264,0.00228676,0.00009742087,0.0001934835,0.007512861],"study_design_scores_gemma":[0.9544889,0.03908378,0.0004539029,0.00006213519,0.0005935254,0.00001099577,0.0008782817,0.0006176771,0.002879546,0.00008146839,0.0007593731,0.00009035382],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9786717,0.0006958747,0.00002354455,0.005506909,0.00004525828,0.01403967,0.00005144671,0.00001466686,0.0009509688],"genre_scores_gemma":[0.9871036,0.0007758833,0.0008037545,0.00002775521,0.00009548404,0.009780367,0.0001077476,0.00002113144,0.001284228],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03743239,"threshold_uncertainty_score":0.3325107,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1222225973170984,"score_gpt":0.4218269267105545,"score_spread":0.2996043293934561,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}